Type of course

Admission requirements

PhD students or holders of a Norwegian master´s degree of five years or 3+ 2 years in pharmacy or molecular sciences (or equivalent, such as chemistry, biochemistry or biotechnology) may be admitted. Valid documentation is a statement from your institution that you are a registered PhD student, or a Master´s Diploma with Diploma Supplement / English translation of the diploma.

Students should preferably have a good background in analytical chemistry.

Course content

The course will give a deeper understanding of the following themes:

• Chromatography and detectors.
• Peptide synthesis and analysis.
• Instrumentation for mass spectrometry
• Practical use of analytical methods

The course will also give an introduction to metabolomics and proteomics.

Objectives of the course

Knowledge

The candidate…

• shall have a high knowledge within the strenghts and weaknesses of different chromatographic systems given a specific analytical challenge.
• shall have a high knowledge within the strenghts and weaknesses of different mass spectrometers given a specific analytical challenge.
• shall have high knowledge of methods and instrumentation for peptide synthesis and analysis.

Skills

The candidate…

• can handle complex questions about choice of extraction and analytical methods based on chemical structure and information about the sample matrix.
• can evaluate different chromatographic methods up against each other based on the analytical challenge.
• can set up small projects within metabolomics and proteomics that can contribute to develop new knowledge.

General competence

The candidate…

• can plan and implement analytical projects based on theoretical knowledge of the selected analyte and available analytical equipment.
• can identify relevant ethical questions regarding the research and perform the research with scientific integrity.

Language of instruction and examination

Teaching methods

• Lectures
• Seminars
• Presentation of articles and discussion

The course is given intensively over 3 weeks.